BSE Live
Sep 05, 16:01Prev. Close
3325.75
Open Price
3318.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:51Prev. Close
3319.40
Open Price
3309.00
Bid Price (Qty.)
3249.60 (7)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Dr Lal PathLabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 59.70 | 46.25 | 35.28 | 41.61 | 33.93 | |
Diluted EPS (Rs.) | 59.61 | 46.18 | 35.17 | 41.48 | 33.85 | |
Cash EPS (Rs.) | 75.54 | 55.21 | 44.92 | 50.32 | 41.98 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 255.32 | 227.56 | 202.70 | 177.15 | 146.03 | |
Book Value [InclRevalReserve]/Share (Rs.) | 255.32 | 227.56 | 202.70 | 177.15 | 146.03 | |
Dividend / Share(Rs.) | 24.00 | 24.00 | 12.00 | 12.00 | 20.00 | |
Revenue from Operations/Share (Rs.) | 281.32 | 235.60 | 212.20 | 224.69 | 178.84 | |
PBDIT/Share (Rs.) | 92.94 | 74.19 | 60.85 | 67.58 | 55.03 | |
PBIT/Share (Rs.) | 76.89 | 65.02 | 51.00 | 58.54 | 46.66 | |
PBT/Share (Rs.) | 74.32 | 61.81 | 46.88 | 55.12 | 44.88 | |
Net Profit/Share (Rs.) | 59.49 | 46.04 | 35.07 | 41.28 | 33.61 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 33.03 | 31.49 | 28.67 | 30.07 | 30.77 | |
PBIT Margin (%) | 27.33 | 27.59 | 24.03 | 26.05 | 26.08 | |
PBT Margin (%) | 26.41 | 26.23 | 22.09 | 24.53 | 25.09 | |
Net Profit Margin (%) | 21.14 | 19.54 | 16.52 | 18.37 | 18.79 | |
Return on Networth / Equity (%) | 23.29 | 20.23 | 17.30 | 23.30 | 23.01 | |
Return on Capital Employed (%) | 28.79 | 27.26 | 22.52 | 27.65 | 29.44 | |
Return on Assets (%) | 18.97 | 15.91 | 12.60 | 15.54 | 17.80 | |
Total Debt/Equity (X) | 0.00 | 0.04 | 0.14 | 0.23 | 0.00 | |
Asset Turnover Ratio (%) | 0.93 | 0.83 | 0.78 | 0.99 | 94.75 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 3.29 | 2.17 | 1.87 | 1.55 | 4.32 | |
Quick Ratio (X) | 3.21 | 2.10 | 1.82 | 1.46 | 4.16 | |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 38.28 | |
Dividend Payout Ratio (NP) (%) | 40.20 | 51.89 | 34.00 | 33.62 | 35.38 | |
Dividend Payout Ratio (CP) (%) | 31.66 | 43.27 | 26.55 | 27.59 | 28.32 | |
Earnings Retention Ratio (%) | 59.80 | 48.11 | 66.00 | 66.38 | 64.62 | |
Cash Earnings Retention Ratio (%) | 68.34 | 56.73 | 73.45 | 72.41 | 71.68 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 19,947.40 | 18,288.37 | 14,941.29 | 21,534.52 | 21,676.61 | |
EV/Net Operating Revenue (X) | 8.48 | 9.30 | 8.45 | 11.50 | 14.54 | |
EV/EBITDA (X) | 25.67 | 29.53 | 29.45 | 38.23 | 47.26 | |
MarketCap/Net Operating Revenue (X) | 8.81 | 9.60 | 8.61 | 11.60 | 15.14 | |
Retention Ratios (%) | 59.79 | 48.10 | 65.99 | 66.37 | 64.61 | |
Price/BV (X) | 9.71 | 9.94 | 9.02 | 14.72 | 18.54 | |
Price/Net Operating Revenue | 8.81 | 9.60 | 8.61 | 11.60 | 15.14 | |
Earnings Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak